Home > Publications database > 'Watching the Detectives' report of the general assembly of the EU project DETECTIVE Brussels, 24-25 November 2015. > print

001     125813
005     20240228143333.0
024 7 _ |a 10.1007/s00204-016-1719-6
|2 doi
024 7 _ |a pmid:27129694
|2 pmid
024 7 _ |a pmc:PMC5435100
|2 pmc
024 7 _ |a 0003-9446
|2 ISSN
024 7 _ |a 0340-5761
|2 ISSN
024 7 _ |a 1432-0738
|2 ISSN
037 _ _ |a DKFZ-2017-01937
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Fernando, Ruani N
|b 0
245 _ _ |a 'Watching the Detectives' report of the general assembly of the EU project DETECTIVE Brussels, 24-25 November 2015.
260 _ _ |a Berlin
|c 2016
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1522050184_13173
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a SEURAT-1 is a joint research initiative between the European Commission and Cosmetics Europe aiming to develop in vitro- and in silico-based methods to replace the in vivo repeated dose systemic toxicity test used for the assessment of human safety. As one of the building blocks of SEURAT-1, the DETECTIVE project focused on a key element on which in vitro toxicity testing relies: the development of robust and reliable, sensitive and specific in vitro biomarkers and surrogate endpoints that can be used for safety assessments of chronically acting toxicants, relevant for humans. The work conducted by the DETECTIVE consortium partners has established a screening pipeline of functional and '-omics' technologies, including high-content and high-throughput screening platforms, to develop and investigate human biomarkers for repeated dose toxicity in cellular in vitro models. Identification and statistical selection of highly predictive biomarkers in a pathway- and evidence-based approach constitute a major step in an integrated approach towards the replacement of animal testing in human safety assessment. To discuss the final outcomes and achievements of the consortium, a meeting was organized in Brussels. This meeting brought together data-producing and supporting consortium partners. The presentations focused on the current state of ongoing and concluding projects and the strategies employed to identify new relevant biomarkers of toxicity. The outcomes and deliverables, including the dissemination of results in data-rich '-omics' databases, were discussed as were the future perspectives of the work completed under the DETECTIVE project. Although some projects were still in progress and required continued data analysis, this report summarizes the presentations, discussions and the outcomes of the project.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Biomarkers
|2 NLM Chemicals
700 1 _ |a Chaudhari, Umesh
|b 1
700 1 _ |a Escher, Sylvia E
|b 2
700 1 _ |a Hengstler, Jan G
|b 3
700 1 _ |a Hescheler, Jürgen
|b 4
700 1 _ |a Jennings, Paul
|b 5
700 1 _ |a Keun, Hector C
|b 6
700 1 _ |a Kleinjans, Jos C S
|b 7
700 1 _ |a Kolde, Raivo
|b 8
700 1 _ |a Kollipara, Laxmikanth
|b 9
700 1 _ |a Kopp-Schneider, Annette
|0 P:(DE-He78)bb6a7a70f976eb8df1769944bf913596
|b 10
|u dkfz
700 1 _ |a Limonciel, Alice
|b 11
700 1 _ |a Nemade, Harshal
|b 12
700 1 _ |a Nguemo, Filomain
|b 13
700 1 _ |a Peterson, Hedi
|b 14
700 1 _ |a Prieto, Pilar
|b 15
700 1 _ |a Rodrigues, Robim M
|b 16
700 1 _ |a Sachinidis, Agapios
|b 17
700 1 _ |a Schäfer, Christoph
|b 18
700 1 _ |a Sickmann, Albert
|b 19
700 1 _ |a Spitkovsky, Dimitry
|b 20
700 1 _ |a Stöber, Regina
|b 21
700 1 _ |a van Breda, Simone G J
|b 22
700 1 _ |a van de Water, Bob
|b 23
700 1 _ |a Vivier, Manon
|b 24
700 1 _ |a Zahedi, René P
|b 25
700 1 _ |a Vinken, Mathieu
|b 26
700 1 _ |a Rogiers, Vera
|b 27
773 _ _ |a 10.1007/s00204-016-1719-6
|g Vol. 90, no. 6, p. 1529 - 1539
|0 PERI:(DE-600)1458459-1
|n 6
|p 1529 - 1539
|t Archives of toxicology
|v 90
|y 2016
|x 1432-0738
909 C O |o oai:inrepo02.dkfz.de:125813
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)bb6a7a70f976eb8df1769944bf913596
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2016
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ARCH TOXICOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b ARCH TOXICOL : 2015
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l Biostatistik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21